Overall, these data reveal that strongly impaired PD-1 inhibition of TCR signalling is required to promote robust effector expansion capable of curbing tumour growth, but such thorough blockade of this inhibitory pathway also caused the loss of high-affinity SLAMF6+ TSL cells. This evidence concerns the gene SLAMF6 and neoplasm.